Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2013 Agents Used in Anemias.

Slides:



Advertisements
Similar presentations
Dr. Soban sadiq. Oral Therapy: Ferrous Sulphate Ferrous Fumarate Ferrous Gluconate Parenteral Therapy: Iron Dextran Iron-sucrose complex Iron sodium.
Advertisements

Anemias where the cells are BIG
Drugs used in the treatment of Anemia
Anti-Anemia Agents Broyles Chapter 22 Lehmkuhl, 2009.
Anemia in chronic kidney disease
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 55 Anemia Drugs.
Agents Used to Treat Anemias. Anemia Decreased number of circulating red blood cells Decreased hemoglobin = decreased oxygen capacity Many causes. 22.
HEMATOPOIETIC AND ANTI- ANEMIA AGENTS February 18, 2014 Thomas M. Guenthner, PhD 407D, MSB
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 55 Drugs for Deficiency Anemias.
Antianemeic drugs Agents to Tr anemia.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
MEGALOBLASTIC ANEMIAS Nada Mohamed Ahmed, MD, MT (ASCP)i.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
1. 2 Vitamin B12 By:Zahra Mahboob Introduction Structure Synthesis Sources Absorbtion Function Deficiencies Treatment Vitamin B12 and Cancer 3 Outline.
Megaloblastic anemias MA are a group of disorders characterized by defective nuclear maturation caused impaired DNA synthesis. This is usually due to vitamin.
1 Antianemeic drugs Agents to Tr anemia Dr Alia Alshanawani.
Antianemics Prof. Hanan Hagar
Iron Toxicity. Overview Principle of the disease Clinical features Diagnosis management.
Anemias. Body Contents of Iron Structure of Hemoglobin.
Vitamins B 6 and B 12 General biochemistry Functions Deficiency diseases.
Agents Used In Anemias HAEMATINICS.
Iron Metabolism HMIM224.
بسم الله الرحمن الرحيم 1. Yazdanpanah SBMU 1. Agents Used in Anemias 2. Hematopoietic Growth Factors Dr. Yazdanpanah Pharmacology/Toxicology Dept. Shaheed.
PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Chapter 5: Porphyrins and Hemoglobin Overview.
Dr. Sadia Batool Shahid PGT-M-Phil, Pharmacology
 Stored in the body as ferritin  Deficiency result from negative iron balance due to depletion of stores and/or inadequate intake.  Iron deficiency.
Control of erythropoiesis, iron metabolism, and hemoglobin
TRACE ELEMENTS IRON. IRON METABOLISM DISTRIBUTION OF IRON IN THE BODY Between 50 to 70 mmol (3 to 4 g) of iron are distributed between body compartments.
1 ANTI - ANEMIC DRUGS BY: Dr.Abdul latif Mahesar.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 56 Blood-Forming Drugs.
Qassim Univ., College of Medicine The Hemopoietic and Immune Systems Phase II, Year II Iron metabolism Dr. Tarek A. Salem Biochemistry.
What is Anemia? Anemia is having less than normal number of red blood cells or less hemoglobin than normal in the blood. *Microcytic Anemia: Any abnormal.
Haematopoietic agents & Erythropoeitin
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Metabolism of iron Alice Skoumalová. Iron in an organism:  total 3-4 g (2,5 g in hemoglobin)  heme, ferritin, transferrin  two oxidation states: Fe.
Iron. Micronutrients : (intake does not exceed 100 mg daily) Daily intake Body stores Zinc 10 mg2200 mg Copper 2.5 mg70 mg Iron 1-2 mg 4000 mg Manganese.
AGENTS FOR MEGALOBLASTIC ANEMIAS. Megaloblastic anemia is treated with folic acid and vitamin B12. Folate deficiencies usually occur secondary to increased.
AGENTS USED FOR IRON DEFICIENCY
Nada Mohamed Ahmed, MD, MT (ASCP)i. Definition. Physiology of iron. Causes of iron deficiency. At risk group. Stages of IDA (pathophysiology). Symptoms.
Drugs used in Anemia :Lecture outline 1. Definition 2. Types of supplements 3. Clinical pharmacology for each 4. Important indications and adverse effects.
Nutritional Anaemias. Iron Found in most animal products – not so available from vegetarian diet Body does not easily absorb or lose iron Deficiency state.
Objectives : When you complete this section ,you should be able to :
 A 30 year old male presents to you with complaints of easy fatigability, lack of concentration, breathlessness on performing normal daily activities.
Dr. Sanjib Das MD. VII.Drugs for Treating Anemia A. Pharmacology Understand the basic concepts of erythropoiesis and its regulation by erythropoietin.
Hematologic Problems Klecka, Spring 2016.
Malabsorption Approach to the patient. Hx, Sx, initial preliminary observation Extensive small-intestinal resection for mesenteric ischemia –Short bowel.
Professor A.M.A Abdel Gader MD, PhD, FRCP (Lond., Edin), FRSH (London) Professor of Physiology, College of Medicine King Khalid University Hospital Riyadh,
Haematinic Drugs Course: Pharmacology I Course Code: PHR 213 Course Instructor: Ms. Sarah Zaheen Lecturer Department of Pharmacy BRAC University.
Haematinic Drugs Course: Pharmacology I Course Code: PHR 213 Course Instructor: Md. Samiul Alam Rajib Senior Lecturer Department of Pharmacy BRAC University.
DRUGS USED TO TREAT DISEASES OF THE BLOOD Presented by Dr. Sasan Zaeri ParmD, PhD March, 2016.
MEGALOBLASTIC ANEMIAS Nada Mohamed Ahmed, MD, MT (ASCP)i.
DRUGS USED TO TREAT Anemias Presented by Dr. Sasan Zaeri ParmD, PhD Fall, 2015.
Drugs Used in Anemia.
ROLE OF IRON IN HEALTH AND DISEASE
Today topics: nutritional requirements for hematopoiesis
Zinc(Zn) At. No. 30 At. Wt. 60. Zinc(Zn) At. No. 30 At. Wt. 60.
BLOOD PHYSIOLOGY Lecture 2
Dr. Muneer Gharaibeh 1.
Today topics: nutritional requirements for hematopoiesis
ANTI-ANEMIC DRUGS By:.
Drugs Used in Anemia.
Nutritional Megaloblastic Anemias
Microminerals (trace elements) Iron
BLOOD PHYSIOLOGY Lecture 2
Vitamins B6 and B12 General biochemistry Functions Deficiency diseases.
Metabolism of iron Alice Skoumalová.
IRON IN HEALTH AND DISEASE Enterocyte Gut ABSORPTION OF IRON Fe+++ Ferritin Fe++ Tf-Fe+++ Fe++ Haem Tf.
Prof. of Medical Biochemistry
Presentation transcript:

Munir Gharaibeh, MD, PhD, MHPE Department of Pharmacology Faculty of Medicine October 2013 Agents Used in Anemias

Hematopoiesis: Requires a constant supply of: 1. Essential elements: Iron, vitamin B12and folic acid. 2. Hematopoietic Growth Factors August 152Munir Gharaibeh MD, PhD, MHPE

IRON Iron deficiency is the most common cause of chronic anemia. Iron deficiency is the most common cause of chronic anemia. Causes microcytic hypochromic anemia. Causes microcytic hypochromic anemia. August 153Munir Gharaibeh MD, PhD, MHPE

August 15 4

IRONPharmacokinetics: Free iron is toxic. Free iron is toxic. All iron used to support hematopoiesis is reclaimed from catalysis of hemoglobin in senescent or damaged erythrocytes. All iron used to support hematopoiesis is reclaimed from catalysis of hemoglobin in senescent or damaged erythrocytes. Only a small amount of iron is lost from the body. Only a small amount of iron is lost from the body. Possibilities of Iron Deficiency: Increased iron requirements Increased iron requirements Increased iron losses. Increased iron losses. August 155Munir Gharaibeh MD, PhD, MHPE

IRON Absorption: Daily intake: 10-15mg of elemental iron. Daily intake: 10-15mg of elemental iron. Heme iron in meat hemoglobin and myoglobin is absorbed intact. Heme iron in meat hemoglobin and myoglobin is absorbed intact. Iron from less available and should be reduced to ferrous iron before it can be absorbed. Iron from other sources is tightly bound to organic compounds and is less available and should be reduced to ferrous iron before it can be absorbed. Daily absorption: 5-10% of the daily intake, usually from duodenum and proximal jejunum. Daily absorption: 5-10% of the daily intake, usually from duodenum and proximal jejunum. Absorption can increase in response to low iron or increased requirements. Absorption can increase in response to low iron or increased requirements. August 156Munir Gharaibeh MD, PhD, MHPE

IRON Absorption: Divalent Metal Transporter (DMT1). Divalent Metal Transporter (DMT1). Active transport. Active transport. Transports ferrous iron across the luminal membrane of intestine. Transports ferrous iron across the luminal membrane of intestine. Regulated by mucosal cell iron stores. Regulated by mucosal cell iron stores. Ferroportin1(IREG1), transports iron across the basolateral membrane into the blood. Ferroportin1(IREG1), transports iron across the basolateral membrane into the blood. Excess iron is stored in the mucosa as ferritin, ( a water-soluble complex consisting of a core of ferric hydroxide covered by a shell of specialized protein called apoferritin). Excess iron is stored in the mucosa as ferritin, ( a water-soluble complex consisting of a core of ferric hydroxide covered by a shell of specialized protein called apoferritin). August 157Munir Gharaibeh MD, PhD, MHPE

IRON Transport: Transferrin (Tf) binds two molecules of iron in the plasma. Transferrin (Tf) binds two molecules of iron in the plasma. The complex binds to Transferrin Receptors (TfR) on the maturing erythroid cells which internalize the complex through the process of receptor-mediated endocytosis. The complex binds to Transferrin Receptors (TfR) on the maturing erythroid cells which internalize the complex through the process of receptor-mediated endocytosis. Iron is released for hemoglobin synthesis. Iron is released for hemoglobin synthesis. Transferrin- transferrin receptor complex is recycled to the plasma membrane and transferrin dissociates and returns to the plasma. Transferrin- transferrin receptor complex is recycled to the plasma membrane and transferrin dissociates and returns to the plasma. TfR is increased with increased erythropoiesis. TfR is increased with increased erythropoiesis. Tf concentration increases with iron depletion and with iron deficiency anemia. Tf concentration increases with iron depletion and with iron deficiency anemia. August 158Munir Gharaibeh MD, PhD, MHPE

IRON Storage: Ferritin( apoferritin AF and iron) is the storage form of iron. Ferritin( apoferritin AF and iron) is the storage form of iron. Intestinal mucosa and in macrophages in the liver, spleen, and bone. Intestinal mucosa and in macrophages in the liver, spleen, and bone. Ferritin in serum is in equilibrium with storage ferritin and can estimate body iron stores. Ferritin in serum is in equilibrium with storage ferritin and can estimate body iron stores. August 159Munir Gharaibeh MD, PhD, MHPE

IRON Elimination: There is no mechanism for excretion. There is no mechanism for excretion. Small amounts are lost by exfoliation of intestinal mucosal cells, bile, urine and sweat. Small amounts are lost by exfoliation of intestinal mucosal cells, bile, urine and sweat. August 1510Munir Gharaibeh MD, PhD, MHPE

August 1511Munir Gharaibeh MD, PhD, MHPE

IRON Indications: Treatment and prevention of iron deficiency anemia: Treatment and prevention of iron deficiency anemia: Increased requirements: infants, children, pregnant and lactating women, patients on hemodialysis, patients on erythropoietin treatment. Increased requirements: infants, children, pregnant and lactating women, patients on hemodialysis, patients on erythropoietin treatment. Inadequate iron absorption: after gastrectomy, severe small bowel disease. Inadequate iron absorption: after gastrectomy, severe small bowel disease. Blood loss: acute or chronic, most common cause of iron deficiency anemia. Blood loss: acute or chronic, most common cause of iron deficiency anemia. August 1512Munir Gharaibeh MD, PhD, MHPE

August 1513Munir Gharaibeh MD, PhD, MHPE

August 1514Munir Gharaibeh MD, PhD, MHPE

August 15 15

IRON Oral Iron Preparations: Ferrous sulfate. Ferrous sulfate. Ferrous gluconate. Ferrous gluconate. Ferrous fumarate. Ferrous fumarate. –All are effective and inexpensive. –Can cause nausea, epigastric discomfort, cramps, constipation or diarrhea and black stools. August 1516Munir Gharaibeh MD, PhD, MHPE

IRON Parenteral Iron Therapy: –Reserved for patients with documented iron deficiency who are unable to tolerate or absorb oral iron and for patients with extensive chronic blood loss who can not be effectively maintained with oral iron alone. –Can cause iron overload. August 1517Munir Gharaibeh MD, PhD, MHPE

IRON Iron dextran: Iron dextran: –Given by deep IM injection or IV infusion. –IM injection causes local pain and tissue staining. –IV infusion causes hypersensitivity reactions: headache, fever, arthralgia, N, V, back pain, flushing, bronchospasm and rarely anaphylaxis and death. Iron-sucrose complex. Iron-sucrose complex. Iron sodium gluconate. Iron sodium gluconate. –Given only IV, less likely to cause hypersensitivity. August 1518Munir Gharaibeh MD, PhD, MHPE

IRON Acute Iron Toxicity: Usually results from accidental ingestion by children. Usually results from accidental ingestion by children. 10 tablets can be lethal in children. 10 tablets can be lethal in children. Causes necrotizing gastroenteritis: vomiting, pain, bloody diarrhea, shock, lethargy and dyspnea. Causes necrotizing gastroenteritis: vomiting, pain, bloody diarrhea, shock, lethargy and dyspnea. Patients may improve but may proceed to metabolic acidosis, coma and death. Patients may improve but may proceed to metabolic acidosis, coma and death. August 1519Munir Gharaibeh MD, PhD, MHPE

IRON Treatment of Acute Iron Toxicity: Deferoxamine” Desferal”: is a potent iron- chelating compound which binds already absorbed iron and promotes its excretion in urine and feces. Deferoxamine” Desferal”: is a potent iron- chelating compound which binds already absorbed iron and promotes its excretion in urine and feces. Whole Bowel Irrigation; to flush out unabsorbed pills. Whole Bowel Irrigation; to flush out unabsorbed pills. Activated charcoal is ineffective. Activated charcoal is ineffective. Supportive therapy is also necessary. Supportive therapy is also necessary. August 1520Munir Gharaibeh MD, PhD, MHPE

IRON Chronic Iron Toxicity= Hemochromatosis: deposits of iron in the heart, liver, pancreas, and other organs leading to organ failure. Usually occurs in: Usually occurs in: 1. Inherited Hemochromatosis: excessive iron absorption. 2.Patients with frequent transfusions e.g. in patients with hemolytic anemias.. August 1521Munir Gharaibeh MD, PhD, MHPE

IRON Chronic Iron Toxicity: Treatment is by: Intermittent phlebotomy. Deferoxamine: is much less efficient than phlebotomy. Deferasirox” Exjade”: oral, more convenient than deferoxamine. August 1522Munir Gharaibeh MD, PhD, MHPE

August 1523Munir Gharaibeh MD, PhD, MHPE

Vitamin B 12 Porphyrin-like ring with a central cobalt atom. Porphyrin-like ring with a central cobalt atom. Methylcobalamine …... Active form. Methylcobalamine …... Active form. Deoxyadenosyl cobalamine. ……... Active. Deoxyadenosyl cobalamine. ……... Active. Cyanocobalamine. Cyanocobalamine. Hydroxocobalamine. Hydroxocobalamine. Source is microbial. Source is microbial. Meat (liver), eggs and dairy products. Meat (liver), eggs and dairy products. Nutritional deficiency only occurs in strict vegetarians. Nutritional deficiency only occurs in strict vegetarians. August 1524Munir Gharaibeh MD, PhD, MHPE

Vitamin B 12 Daily requirement : 2mcg Daily requirement : 2mcg Storage pool: mcg. Storage pool: mcg. It would take 5 years to exhaust all the stored pool and for megaloblastic anemia to develop after stopping absorption. It would take 5 years to exhaust all the stored pool and for megaloblastic anemia to develop after stopping absorption. August 1525Munir Gharaibeh MD, PhD, MHPE

Pharmacokinetics of Vitamin B 12 Absorption requires the complexing with the: Intrinsic Factor, which is a glycoprotein secreted by the parietal cells of the stomach. Absorption requires the complexing with the: Intrinsic Factor, which is a glycoprotein secreted by the parietal cells of the stomach. Transported in the body by Transcobalamine II. Transported in the body by Transcobalamine II. Schilling Test: –Measures absorption and urinary excretion of radioactively labeled Vitamin B 12. August 1526Munir Gharaibeh MD, PhD, MHPE

Vitamin B 12 Deficiency Pernicious anemia. Distal ileal disease e.g. Inflammation or resection or Diphyllobothrium latum infestation. Bacterial overgrowth of the small intestine. Bacterial overgrowth of the small intestine. Chronic pancreatitis. Chronic pancreatitis. Thyroid disease. Thyroid disease. Congenital deficiency of the intrinsic factor. Congenital deficiency of the intrinsic factor. Congenital selective Vitamin B 12 malabsorption Congenital selective Vitamin B 12 malabsorption August 1527Munir Gharaibeh MD, PhD, MHPE

Actions of Vitamin B Transfer of a methyl group from N 5 -methyltetrahydrofolate to homocysteine, forming methionine. N 5 -methyltetrahydrofolate is the major dietary and storage folate. 2. Conversion of N 5 -methyltetrahydrofolate to tetrahydrofolate. Deficiency leads to accumulation of N 5 - methyltetrahydrofolate cofactors and depletion of tetrahydrofolate = Methylfolate Trap. Methylfolate Trap. August 1528Munir Gharaibeh MD, PhD, MHPE

Vitamin B 12 Megaloblastic anemia of Vitamin B 12 deficiency can be partially corrected by ingestion of large amounts of folic acid. This is because folic acid can be reduced to dihydrofolate by the enzyme dihydrofolate reductase. August 1529Munir Gharaibeh MD, PhD, MHPE

Actions of Vitamin B Isomerization of methylmalonyl- CoA to succinyl-CoA by the enzyme methylmalonyl-CoA mutase. Vitamin B 12 depletion leads to the accumulation of methylmalonyl-CoA, thought to cause the neurological manifestations of Vitamin B 12 deficiency. Vitamin B 12 depletion leads to the accumulation of methylmalonyl-CoA, thought to cause the neurological manifestations of Vitamin B 12 deficiency. August 1530Munir Gharaibeh MD, PhD, MHPE

August 1531Munir Gharaibeh MD, PhD, MHPE

Vitamin B 12 Parenteral : Life-long treatment. Daily or every other day for 1-2 weeks to replenish the stores. Maintenance: injections every 1-4 weeks. Oral: Only for patients who refuse or can not tolerate injections. Intranasal: For patients in remission. August 1532Munir Gharaibeh MD, PhD, MHPE

Folic Acid Folic Acid Reduced forms of folic acid are required for the synthesis of amino acids, purines and DNA. Reduced forms of folic acid are required for the synthesis of amino acids, purines and DNA. Deficiency is common but easily corrected. Deficiency is common but easily corrected. Deficiency can result in: Deficiency can result in: Megaloblastic anemia. Megaloblastic anemia. Congenital malformations. Congenital malformations. Occlusive Vascular disease due to elevated homocysteine. Occlusive Vascular disease due to elevated homocysteine. August 1533Munir Gharaibeh MD, PhD, MHPE

Chemistry of Folic Acid Folic acid=Pteridine+ PABA+ Glutamic acid. Folic acid=Pteridine+ PABA+ Glutamic acid. Folic acid is reduced to Di and Tetra hydrofolate and then to folate cofactors, which are interconvertible and can donate one-carbon units at various levels of oxidation. Folic acid is reduced to Di and Tetra hydrofolate and then to folate cofactors, which are interconvertible and can donate one-carbon units at various levels of oxidation. In most cases folic acid is regenerated. In most cases folic acid is regenerated. August 1534Munir Gharaibeh MD, PhD, MHPE

Kinetics of Folic Acid Only 5-20 mcg are stored in the liver. Only 5-20 mcg are stored in the liver. Excreted in urine and stool and also destroyed by catabolism. Excreted in urine and stool and also destroyed by catabolism. So, megaloblastic anemia can develop within 1-6 months after stopping intake. So, megaloblastic anemia can develop within 1-6 months after stopping intake. Present in yeast, liver, kidney and green vegetables. Present in yeast, liver, kidney and green vegetables. August 1535Munir Gharaibeh MD, PhD, MHPE

Kinetics of Folic Acid Readily and completely absorbed from the terminal jejunum ( Worm…?). Readily and completely absorbed from the terminal jejunum ( Worm…?). Glutamyl residues are hydrolyzed before absorption by α-1- glutamyltransferase(Congugase), within the brush border of the mucosa. Glutamyl residues are hydrolyzed before absorption by α-1- glutamyltransferase(Congugase), within the brush border of the mucosa. N 5 -methyltetrahydrofolate is transported into the blood stream by active and passive processes. N 5 -methyltetrahydrofolate is transported into the blood stream by active and passive processes. Widely distributed in the body. Widely distributed in the body. Inside cells, it is converted into THF by demethylation reaction in the presence of Vitamin B 12. Inside cells, it is converted into THF by demethylation reaction in the presence of Vitamin B 12. August 1536Munir Gharaibeh MD, PhD, MHPE

Actions of Folic Acid THF cofactors are important in one- carbon reactions: THF cofactors are important in one- carbon reactions: –Production of dTMP from dUMP, which is needed in DNA synthesis. –Generation of methionine from homocysteine. –Synthesis of essential purines. August 1537Munir Gharaibeh MD, PhD, MHPE

August 1538Munir Gharaibeh MD, PhD, MHPE

August 1539Munir Gharaibeh MD, PhD, MHPE

Megaloblastic Anemia of Folic Acid Deficiency Inadequate dietary intake. Inadequate dietary intake. Alcoholics, due to neglected nutrition. Alcoholics, due to neglected nutrition. Patients with liver disease due to impaired hepatic storage. Patients with liver disease due to impaired hepatic storage. Pregnant women and patients with hemolytic anemia due to increased demand. Pregnant women and patients with hemolytic anemia due to increased demand. Patients with malabsorption syndrome. Patients with malabsorption syndrome. Patients on renal dialysis. Patients on renal dialysis. Drugs: Methotrxate, Trimethoprim and Phenytoin. Drugs: Methotrxate, Trimethoprim and Phenytoin. August 1540Munir Gharaibeh MD, PhD, MHPE

Treatment with Folic Acid Parenteral administration is rarely necessary because it is well absorbed orally even in malabsorption. Parenteral administration is rarely necessary because it is well absorbed orally even in malabsorption. 1 mg daily until cause is corrected. 1 mg daily until cause is corrected. Or, indefinitely for patients with malabsorption or dietary inadequacy. Or, indefinitely for patients with malabsorption or dietary inadequacy. Can be given prophylactically. Can be given prophylactically. Recently supplemented to foods ???. Recently supplemented to foods ???. August 1541Munir Gharaibeh MD, PhD, MHPE